Skip to main content
. 2016 Dec 28;28(6):1839–1850. doi: 10.1681/ASN.2016040412

Table 1.

Study characteristics

Author (Yr Published) Country Recruitment Start Type of Study Cohort Subset Follow-Up (Mo) No. of Fistulas Upper Arm, % First Fistula, % Age, yr Men, % DM, % CAD, % CHD, %
McCarley et al. (2001)58a,b United States 1996 Retrospective NM 11.0 39 . . 55.3 51 36 . .
McCarley et al. (2001)58a,b United States 1996 Retrospective DVPM 12.0 41 . . 56.6 54 36 . .
McCarley et al. (2001)58a,b United States 1997 Retrospective VABFM 10.0 43 . . 56.1 59 34 . .
Tokars et al. (2001)59 United States 1997 Prospective Standard 5.2 . . . . . . . .
Dixon et al. (2002)60 United States 1992 Retrospective Lower arm . 88 0 . 50.9 81 47 39 .
Dixon et al. (2002)60 United States 1992 Retrospective Upper arm . 117 100 . 57.8 56 56 49 .
Ravani et al. (2002)61 Italy 1995 Prospective Standard 20.4 197 19 100 65.7 59 22 . 14
Saxena et al. (2002)62 Saudi Arabia 1996 Prospective Diabetic nasal carriers of MRSA/MSSA 36.0 . . . . . . . .
Saxena et al. (2002)62 Saudi Arabia 1996 Prospective Nondiabetic nasal carriers of MRSA/MSSA 36.0 . . . . . . . .
Stevenson et al. (2002)63 United States 1998 Retrospective Standard . . . . . . . . .
Taylor et al. (2002)64 Canada 1998 Surveillance Standard 6.0 . . . . . . . .
Tokars et al. (2002)65 United States 1999 Prospective Standard . . . . . . . . .
Elseviers et al. (2003)11b Europe 1998 Prospective Standard 12.0 1049 . . . 56 . . .
Lok et al. (2003)66a Canada 1997 Prospective Duplex US Monitoring 9.2 189 30 96 57.5 71 . . .
Lok et al. (2003)66a Canada 1999 Prospective Transonic surveillance 10.4 241 30 96 57.5 71 . . .
Saxena et al. (2003)67b Saudi Arabia 1997 Surveillance Standard . . . . 47.5 54 . . .
Bonforte et al. (2004)68 Italy 1991 Prospective Lower arm 27.0 112 0 . 71 50 22 . .
Astor et al. (2005)69 United States 1995 Prospective Standard 35.9 185 . . 56.8 71 47 42 .
Gilad et al. (2005)70b Israel 2002 Surveillance Standard . . . . 63.5 55 48 44 21
Lok et al. (2005)71 Canada 1995 Retrospective Nonelderly (<65 yr) 65.0 248 44 100 46 65 29 24 15
Lok et al. (2005)71 Canada 1995 Retrospective Elderly (≥65 yr) 51.7 196 53 100 74 69 30 44 29
Mallamaci et al. (2005)72 Italy . Prospective Standard 32.5 205 5 . 59.4 57 14 . .
Shahin et al. (2005)73 United States 1992 Retrospective Standard 21.0 146 51 100 54.9 58 49 53 .
Shahin et al. (2005)73 United States 1999 Retrospective Qa surveillance 19.0 76 61 100 57.6 59 57 68 .
Jennings et al. (2006)74 United States 2003 Retrospective Standard 11.0 134 91 74 61 54 52 . .
Polkinghorne et al. (2006)75 Australia 2001 RCT Standard 16.2 68 34 . 56.4 71 28 29 .
Polkinghorne et al. (2006)75 Australia 2001 RCT Qa surveillance 17.3 69 36 . 60 65 35 28 .
Roozbeh et al. (2006)76a Iran . Prospective Standard 23.0 171 57 . 53 68 27 . .
Huijbregts et al. (2008)5 The Netherlands 2004 Prospective Standard 8.6 285 40 . 64.6 62 33 23 .
Pflederer et al. (2008)77 United States 2004 Retrospective Standard 8.0 321 37 . 64.5 65 43 . .
Pflederer et al. (2008)77 United States 2004 Retrospective AVF-T 8.0 161 100 . 63.3 61 45 . .
Qasaimeh et al. (2008)78b Jordan 2004 Retrospective Standard 12.0 104 . . . 52 32 . .
Tessitore et al. (2008)79c Italy 2002 Prospective Standard 31.0 97 18 . 65.1 64 19 62 .
Tessitore et al. (2008)79c Italy 2002 Prospective Qa Surveillance 30.0 62 21 . 63.4 52 31 69 .
Koksoy et al. (2009)80 Turkey 2003 RCT AVF-T 43.6 50 100 0 54.66 52 32 . .
Koksoy et al. (2009)80 Turkey 2003 RCT Upper arm 39.5 50 100 0 54.78 60 24 . .
Papanikolaou et al. (2009)81 Greece 1986 Retrospective Lower arm . . 100 . . 45 8 . .
Papanikolaou et al. (2009)81 Greece 1986 Retrospective Upper arm . . . . . 45 8 . .
Korkut et al. (2010)15 Turkey 2004 Retrospective AVF-T 48.0 350 100 . 57.8 44 51 15 .
Paul et al. (2010)82 United States 2006 Retrospective Endo/AVF-T 14.0 98 100 47 60 40 49 . .
Paul et al. (2010)82 United States 2006 Retrospective Open/AVF-T 18.0 78 100 41 62 27 56 . .
van Loon et al. (2010)13 The Netherlands 2007 Prospective Rope ladder . 70 39 84 65 67 21 80 .
van Loon et al. (2010)13 The Netherlands 2007 Prospective Buttonhole . 75 51 68 67 59 27 61 .
Jennings et al. (2011)83a United States 2003 Retrospective Elderly (≥65 yr) 17.0 461 38 77 73 49 60 . .
Labriola et al. (2011)84 Belgium 2001 Retrospective Standard 35.1 . 37 . 70.4 66 33 . .
Ng et al. (2011)85 United States 1996 Prospective Standard 6.0 476 . . 61.1 73 49 47 34
Ayez et al. (2012)86 The Netherlands 2000 Retrospective Upper arm 19.0 173 100 68 62.61 52 46 3 57
Renaud et al. (2012)87 Singapore 2008 Retrospective Nonelderly (<65 yr) 12.0 191 41 100 52 60 70 41 .
Renaud et al. (2012)87 Singapore 2008 Retrospective Elderly (≥65 yr) 13.0 89 39 100 72 55 71 49 .
Kandil et al. (2013)88 United Kingdom 2007 Retrospective Buttonhole . 227 . . 63.8 61 46 . .
Lin et al. (2013)14 Taiwan 2008 RCT Infrared 12.0 60 15 100 63.2 53 47 17 .
Lin et al. (2013)14 Taiwan 2008 RCT Standard 12.0 62 18 100 63 57 37 12 .
Macrae et al. (2013)19 Canada 2006 RCT Buttonhole . 70 84 83 77.2 73 49 61 .
Macrae et al. (2013)19 Canada 2006 RCT Standard . 69 75 86 66.1 67 54 42 .
Ravani et al. (2013)12 International 1996 RCT Standard . 3352 . 100 62.2 68 38 36 29
de Albuquerque et al. (2013)89 Brazil 2010 Surveillance Standard . . . . . . . . .
Agarwal et al. (2014)90 United States 2005 Retrospective AVF-T (1-stage) . 61 100 . 59.1 . . . .
Agarwal et al. (2014)90 United States 2005 Retrospective AVF-T (2-stage) . 83 100 . 61.5 . . . .
Badawy et al. (2014)91b Kuwait 2012 Surveillance Standard . . . . 58.1 40 . . .
Lok et al. (2014)92 Canada 2000 Retrospective Rope ladder 29.6 457 . . 58.8 58 36 29 16
Olsha et al. (2014)93 Turkey 2005 Retrospective Elderly (≥80 yr) 17.6 128 71 . 85 66 40 45 24

DM, diabetes mellitus; CAD, coronary artery disease; CHD, Congestive Heart Disease; NM, no monitoring; ., data not reported; DVPM, dynamic venous pressure monitoring; VABFM, vascular access blood flow monitoring; standard, all fistula locations; lower arm, a cohort consisting of patients only fistulas located in the lower arm; upper arm, patients with fistulas located in the upper arm, including transposed brachiobasilic fistulas; MRSA, methicillin‐resistant Staphylococcus aureus; MSSA, methicillin‐sensitive Staphylococcus aureus; duplex US, duplex ultrasound; RCT, randomized controlled trial; AVF-T, transposed arteriovenous fifistula; endo/AVF-T, a transposed arteriovenous fistula created using an endoscopic procedure; open/AVF-T, a transposed arteriovenous fistula created using a long open incision technique; rope ladder, rope ladder cannulation; buttonhole, buttonhole cannulation.

a

Percentage of patients whose diabetes was the cause of kidney failure.

b

Baseline data reported for fistulas and other accesses grouped together.

c

CAD was defined as presence of cardiovascular disease.